Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor

The development of neutralizing antibodies (inhibitors) against factor VIII (FVIII) is a major complication of hemophilia A treatment. The sole clinical therapy to restore FVIII tolerance in patients with inhibitors remains immune tolerance induction (ITI) which is expensive, difficult to administer...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Immunol
Main Authors: Georgescu, Maria T., Moorehead, Paul C., Liu, Tongyao, Dumont, Jennifer, Scott, David W., Hough, Christine, Lillicrap, David
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Immunology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7025534/
https://ncbi.nlm.nih.gov/pubmed/32117285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00138
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker